ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2016

A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer.

Jun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.